Skip to menu Skip to content Skip to footer
Ms

Cui Tu

Email: 

Overview

Availability

Ms Cui Tu is:
Available for supervision

Works

Search Professor Cui Tu’s works on UQ eSpace

3 works between 2024 and 2024

1 - 3 of 3 works

2024

Conference Publication

Natural Killer cell-based cancer immunotherapy for rhabdomyosarcoma

Rossi, Gustavo Rodrigues, Lam, Pui Yeng, Omer, Natacha, Tu, Cui and Souza-Fonseca-Guimaraes, Fernando (2024). Natural Killer cell-based cancer immunotherapy for rhabdomyosarcoma. Annual Meeting of the American Association of Immunologists (IMMUNOLOGY), Chicago, IL, United States, 3-7 May 2024. Cary, NC, United States: Oxford University Press. doi: 10.4049/jimmunol.212.supp.1399.5214

Natural Killer cell-based cancer immunotherapy for rhabdomyosarcoma

2024

Conference Publication

Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment

Tu, Cui, Tan, Chin Wee, Liu, Ning, Kulasinghe, Arutha and Souza-Fonseca-Guimaraes, Fernando (2024). Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-73

Spatial profiling of pediatric rhabdomyosarcoma to elucidate their immunosuppressive tumor microenvironment

2024

Journal Article

Leveraging spatial omics for the development of precision sarcoma treatments

Tu, Cui, Kulasinghe, Arutha, Barbour, Andrew and Souza-Fonseca-Guimaraes, Fernando (2024). Leveraging spatial omics for the development of precision sarcoma treatments. Trends in Pharmacological Sciences, 45 (2), 134-144. doi: 10.1016/j.tips.2023.12.006

Leveraging spatial omics for the development of precision sarcoma treatments

Funding

Current funding

  • 2025 - 2027
    Advancing insights into the immune landscape of pediatric ARDS lungs: A spatial multi-omics approach
    UQ - Sanofi Translational Science Hub Partnership Scheme
    Open grant
  • 2025 - 2026
    First-in-field combinatorial therapy using anti-tumoral STING agonist to enhance chemotherapy effectiveness for hard-to-cure rhabdomyosarcomas
    ANZ Sarcoma Research Grant
    Open grant
  • 2024 - 2029
    Pseudomyxoma Perionei Research Program
    PA Research Foundation
    Open grant

Supervision

Availability

Ms Cui Tu is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Ms Cui Tu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au